A phase II study of recombinant interferon-gamma following combination chemotherapy for patients with extensive small cell lung cancer. CALGB. [electronic resource]
Producer: 19950307Description: 67-70 p. digitalISSN:- 0277-3732
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Carcinoma, Small Cell -- therapy
- Cisplatin -- administration & dosage
- Cyclophosphamide -- administration & dosage
- Doxorubicin -- administration & dosage
- Drug Administration Schedule
- Etoposide -- administration & dosage
- Female
- Humans
- Infusions, Intravenous
- Interferon-gamma -- therapeutic use
- Lung Neoplasms -- therapy
- Male
- Middle Aged
- Recombinant Proteins
- Survival Analysis
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.